Exelixis (EXEL) EBT Margin (2010 - 2026)

Exelixis (EXEL) recorded quarterly EBT Margin of 43.82% in Q2 2026, up 3.83% quarter-over-quarter from 42.21% in Q1 2026, and up 679.0% on a YoY basis from 5.63% in Q2 2025.

Exelixis (EXEL) EBT Margin (2010 - 2026) Analysis & Trends

Exelixis' EBT Margin history runs 17 years deep, the most recent figure standing at 43.82% for Q2 2026.

  • In Q2 2026, EBT Margin rose 679.0% year-over-year to 43.82%; the TTM figure through Apr 2026 stood at 42.23% (up 578.0% YoY), while the FY2026 annual figure was 40.57%, up 914.0% from the prior year.
  • EBT Margin was 43.82% for Q2 2026 at Exelixis, up from 42.21% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 45.96% in Q2 2024 to a low of 7.41% in Q4 2022.
  • Historically, EBT Margin has averaged 25.91% across 5 years, with a median of 23.94% in 2022.
  • Biggest YoY gain for EBT Margin was 2890 bps in 2023; the steepest drop was 2112 bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 7.41% in 2022, then surged by 390 bps to 21.48% in 2023, then surged by 34 bps to 28.68% in 2024, then jumped by 47 bps to 42.23% in 2025, then climbed by 4 bps to 43.82% in 2026.
  • The last three EBT Margin figures came in at 43.82% (Q2 2026), 42.21% (Q1 2026), and 42.23% (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 6.40%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 41.95%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Exelixis 13.37 Bn 12.59 Bn 590.86 Mn 43.82%

Historic Data

Download Data
DateValue
Apr 3, 2026 43.82%
Jan 2, 2026 42.21%
Oct 3, 2025 42.23%
Jul 4, 2025 40.55%
Apr 4, 2025 37.03%
Jan 3, 2025 32.60%
Sep 27, 2024 28.68%
Jun 28, 2024 45.96%
Mar 29, 2024 11.59%
Dec 29, 2023 21.48%
Sep 29, 2023 1.23%
Jun 30, 2023 21.37%
Mar 31, 2023 11.81%
Dec 30, 2022 -7.41%
Sep 30, 2022 22.35%
Jul 1, 2022 21.10%
Apr 1, 2022 23.94%
Oct 1, 2021 16.22%
Jul 2, 2021 32.42%
Apr 2, 2021 -0.75%